A model of isoniazid treatment of tuberculosis

Journal of Theoretical Biology

Volumn 363, Issue , 2014, Pages 367-373

  Lemmer, Yolandy ^a   Grobler, Anne ^b   Moody, Clint ^c   Viljoen, Hendrik ^b,c  

^a DSI CSIR Nanotechnology Innovation Centre   (South Africa)

^b NORTH WEST UNIVERSITY   (South Africa)

^c UNIVERSITY OF NEBRASKA LINCOLN   (United States)

Author keywords

Cell wall; Drug resistance; Efflux pumps; Mathematical model; Mycolic acid

Indexed keywords

ISONIAZID; MYCOLIC ACID;

BACTERIUM; CELL ORGANELLE; DISEASE TREATMENT; DRUG RESISTANCE; GROWTH RESPONSE; NUMERICAL MODEL; PLASMA; TUBERCULOSIS;

ANTIBIOTIC SENSITIVITY; ARTICLE; AUTOLYSIS; BACTERIAL CELL WALL; BACTERIAL GROWTH; BACTERICIDAL ACTIVITY; CELL DEATH; CELL LEVEL; CELL VIABILITY; DOSE RESPONSE; DRUG BLOOD LEVEL; DRUG DIFFUSION; DRUG EFFECT; FATTY ACID SYNTHESIS; GRANULOMA; INHIBITION KINETICS; MATHEMATICAL ANALYSIS; MATHEMATICAL MODEL; MINIMUM INHIBITORY CONCENTRATION; MYCOBACTERIUM TUBERCULOSIS; PREDICTION; THICKNESS; TUBERCULOSIS; BIOLOGICAL MODEL; CELL WALL; DIFFUSION; DRUG EFFECTS; MICROBIOLOGY; PHYSIOLOGY;

CELL WALL; DIFFUSION; GRANULOMA; ISONIAZID; MODELS, BIOLOGICAL; MYCOBACTERIUM TUBERCULOSIS; TUBERCULOSIS;

EID: 84907481004     PISSN: 00225193     EISSN: 10958541     Source Type: Journal    
DOI: 10.1016/j.jtbi.2014.07.024     Document Type: Article

References (33)

1. Aldridge B.B., Fernandez-Suarez M., Heller D., Ambravaneswaran V., Irimia D., Toner M., Fortune S.M. Asymmetry and aging of mycobacterial cells lead to variable growth and antibiotic susceptibility. Science (New York, N.Y.) 2012, 335(6064):100-104. 10.1126/science.1216166.
2. Appelbaum P.C. The emergence of vancomycin-intermediate and vancomycin-resistant Staphylococcus aureus. Clin. Microbiol. Infect.: Off. Publ. Eur. Soc. Clin. Microbiol. Infect. Dis. 2006, 12(Suppl 1):S16-S23.
3. Blanchard J.S. Molecular mechanisms of drug resistance in Mycobacterium tuberculosis. Annu. Rev. Biochem. 1996, 65:215-239.
4. Bardou Fabienne, et al. Mechanism of isoniazid uptake in Mycobacterium tuberculosis. Microbiology 1998, 144.9:2539-2544.
5. Cui L., Ma X., Sato K., Okuma K., Tenover F.C., Mamizuka E.M., et al. Cell wall thickening is a common feature of vancomycin resistance in Staphylococcus aureus. J. Clin. Microbiol. 2003, 41(1):5-14.
6. Dartois V. The path of anti-tuberculosis drugs: from blood to lesions to mycobacterial cells. Nat. Rev. 2014, 12:159-167.
7. De Boer W.R., Meyer P.D., Jordens G.J., Kruyssen F.J., Wouters J.T.M. Cell wall turnover in growing and nongrowing cultures of Bacillus subtilis. J. Bacteriol. 1982, 149:977-984.
8. Doyle R.J., Chaloupka J., Vinter V. Turnover of cell walls in microorganisms. Microbiol. Rev. 1988, 52(4):554-567.
9. Eagle H., Musselman A.D. The rate of bactericidal action of penicillin in vitro as a function of its concentration, and its paradoxically reduced activity at high concentrations against certain organisms. J. Exp. Med. 1948, 88:99-131.
10. Eagle H. A paradoxical zone phenomenon in the bactericidal action of penicillin in vitro. Science (New York, N.Y.) 1948, 107(2767):44-45.
11. Fleischhacker M., Radecke C., Schulz B., Ruhnke M. Paradoxical growth effects of the echinocandins caspofungin and micafungin, but not of anidulafungin, on clinical isolates of candida albicans and C. dubliniensis. Eur. J. Clin. Microbiol. Infect. Dis.: Off. Publ. Eur. Soc. Clin. Microbiol. 2008, 27(2):127-131.
12. Gillespie S. Evolution of drug resistance in Mycobacterium tuberculosis: clinical and molecular perspective. Antimicrob. Agents Chemother. 2002, 46:267-274.
13. Grandiere-Perez L., Jacqueline C., Lemabecque V., Patey O., Potel G., Caillon J. Eagle effect in corynebacterium diphtheriae. J. Infect. Dis. 2005, 191(12):2118-2120.
14. Grobler A.F. Pharmaceutical Applications of Pheroid Technology 2009, (Ph. D. thesis), North-West University, Potchefstroom, South Africa.
15. Gustafson J.E., Wilkinson B.J. Lower autolytic activity in a homogeneous methicillin-resistant staphylococcus aureus strain compared to derived heterogeneous-resistant and susceptible strains. FEMS Microbiol. Lett. 1989, 59(1-2):107-111.
16. Hanaki H., Kuwahara-Arai K., Boyle-Vavra S., Daum R.S., Labischinski H., Hiramatsu K. Activated cell-wall synthesis is associated with vancomycin resistance in methicillin-resistant staphylococcus aureus clinical strains Mu3 and Mu50. J. Antimicrob. Chemother. 1998, 42(2):199-209.
17. Hazbon M.H., et al. Population genetics study of isoniazid resistance mutations and evolution of multidrug resistant Mycobacterium tuberculosis. Antimicrob. Agents Chemother. 2006, 50:2640-2649.
18. Hett E.C., Rubin E.J. Bacterial growth and cell division: a mycobacterial perspective. Microbiol. Mol. Biol. Rev. 2008, 72(1):126-156.
19. Kondo N., Kuwahara-Arai K., Kuroda-Murakami H., Tateda-Suzuki E., Hiramatsu K. Eagle-type methicillin resistance: new phenotype of high methicillin resistance under mec regulator gene control. Antimicrob. Agents Chemother. 2001, 45(3):815-824.
20. Lemmer Y. Assessment of Mycolic Acids as Ligand for Nanoencapsulated Anti-Tuberculosis Drug Targeting 2010, (Ph. D. thesis), University of Pretoria.
21. Mahapatra Sebabrata, et al. A novel metabolite of antituberculosis therapy demonstrates host activation of isoniazid and formation of the isoniazid-NAD+ adduct. Antimicrob. Agents Chemother. 2012, 56(1):28-35.
22. Metcalfe Clive, et al. The tuberculosis prodrug isoniazid bound to activating peroxidases. J. Biol. Chem. 2008, 283(10):6193-6200.
23. Mokrousov I., Otten T., Filipenko M., Vyazovaya A., Chrapov E., Limeschenko E., Steklova L., Vyshnevskiy B., Narvskaya O. Detection of isoniazid-resistant Mycobacterium tuberculosis strains by a multiplex allele-specific PCR assay targeting katG codon 315 variation. J. Clin. Microbiol. 2002, 40:2509-2512.
24. Morikawa K., Maruyama A., Inose Y., Higashide M., Hayashi H., Ohta T. Overexpression of sigma factor, sigma(B), urges staphylococcus aureus to thicken the cell wall and to resist beta-lactams. Biochem. Biophys. Res. Commun. 2001, 288(2):385-389.
25. Niki Makoto, et al. A novel mechanism of growth phase-dependent tolerance to isoniazid in mycobacteria. J. Biol. Chem. 2012, 287.33:27743-27752.
26. Nunes A.P., Teixeira L.M., Iorio N.L., Bastos C.C., de Sousa Fonseca L., Souto-Padron T., et al. Heterogeneous resistance to vancomycin in staphylococcus epidermidis, staphylococcus haemolyticus and staphylococcus warneri clinical strains: Characterisation of glycopeptide susceptibility profiles and cell wall thickening. Int. J. Antimicrob. Agents 2006, 27(4):307-315.
27. Park J.T., Uehara T. How bacteria consume their own exoskeletons (turnover and recycling of cell wall peptidoglycan). Microbiol. Mol. Biol. Rev. 2008, 72:211-227.
28. Pienaar E., Whitney S.E., Viljoen H.J., van Rensburg N.F. A model of the complex response of Staphylococcus aureus to methicillin. J. Theor. Biol. 2009, 257:438-445.
29. Rouse David A., et al. Characterization of the katG and inhA genes of isoniazid-resistant clinical isolates of Mycobacterium tuberculosis. Antimicrob. Agents Chemother. 1995, 39.11:2472-2477.
30. Salyers A., Whitt D. Bacterial Pathogenesis A Molecular Approach 2002, ASM Press, Washington D.C.
31. Thanky N.R., Young D.B., Robertson B.D. Unusual features of the cell cycle in mycobacteria: polar-restricted growth and the snapping-model of cell division. Tuberculosis (Edinburgh, Scotland) 2007, 87(3):231-236. 10.1016/j.tube.2006.10.004.
32. Velayati A.A., Farnia P., Ibrahim T.A., Haroun R.Z., Kuan H.O., Ghanavi J., Farnia P., Kabarei A.N., Tabarsi P., Omar A.R., Varahram M., Masjedi M.R. Differences in cell wall thickness between resistant and nonresistant strains of Mycobacterium tuberculosis: using transmission electron microscopy. Chemotherapy 2009, 55(5):303-307.
33. Wong W., Young F.E., Chatterjee A.N. Regulation of bacterial cell walls: turnover of cell walls in Staphylococcus aureus. J. Bacteriol. 1974, 120:837-843.